Why the study?
Are there sex differences in the use of secondary preventive drugs after stroke?
Are there sex differences in the use of secondary preventive drugs after stroke?
Poor persistence to secondary preventive drugs after stroke is a major public health issue, overshadowing minor sex disparities in utilization.
Emphasizes persistence over sex differences in post-stroke prevention; leaves open whether interventions improve adherence in observational data.
This study showed few differences between men and women after stroke. Patients' use of secondary preventive drugs needs to be improved, and from a public health perspective, poor persistence is probably a greater problem than differences between the sexes.
No takes yet. Share an insight, caveat, or question.
Sjölander et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: